Additional capabilities cater to U.S. and European institutional traders seeking one-stop multiple asset class execution management system LONDON, and JERSEY CITY, N.J., April 23 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) announced today enhancements to its electronic trading platform, Knight Direct EMS, that give institutional traders the ability to trade European equities and foreign currencies. A broker-neutral trading platform, Knight Direct EMS offers direct market access to multiple asset classes, including U.S. and non-U.S. equities, futures, options and foreign exchange. "Knight offers an expansive solution for electronic, global trading including direct market access to major European exchanges, low-latency market data and a host of sophisticated functionality such as portfolio trading," said Joseph Wald, Managing Director, Direct Trading Institutional, L.P., a subsidiary of Knight Capital Group. "Institutional traders seeking self-directed connectivity to a wide range of liquidity destinations in a post-MiFID environment can look to our expertise and technology to address their needs." With direct market access to most European exchanges, Knight Direct EMS offers native functionality in each exchange and market, giving U.S. and European traders powerful liquidity management solutions in dealing with fragmentation of the European equities marketplace. In addition to the European equities trading capabilities, Knight has added electronic access to the spot foreign exchange market through subsidiary Hotspot FX, making Knight Direct EMS a virtual one-stop shop for flexible trading capabilities in multiple asset classes. Hotspot provides access to trading in 48 currency pairs as well as gold and silver through a transparent ECN model which supports enhanced trade execution management and transaction cost analysis as well as alpha generation. "With newly added capabilities in European ordinaries and currencies, Knight Direct EMS offers a robust platform to asset managers and hedge funds seeking self-directed trading solutions to efficiently source liquidity across multiple asset classes," said Mr. Wald. Knight Direct EMS is offered through Knight's subsidiaries, Direct Trading Institutional, L.P. and Knight Equity Markets International Ltd. About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is a leading financial services firm that provides electronic and voice access to the capital markets across multiple asset classes for buy-side, sell-side and corporate clients, and asset management for institutions and private clients. Our Global Markets business provides market access and trade execution services in nearly every U.S. equity security and a large number of international securities, futures, options, foreign exchange and fixed income. We offer high-quality trade executions through natural liquidity, capital facilitation and trading technology, with comprehensive products and services that support alpha creation and capital formation. Our Asset Management business, Deephaven Capital Management, is a global multi-strategy alternative investment manager focused on delivering attractive risk-adjusted returns with low correlation to the broader markets. More information about Knight can be found at http://www.knight.com/. Certain statements contained herein, and the documents incorporated by reference, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict including, without limitation, risks associated with the costs, integration, performance and operation of businesses recently acquired, or that may be acquired in the future, by the Company. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein. Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the U.S. Securities and Exchange Commission (SEC), including, without limitation, those detailed under the headings "Certain Factors Affecting Results of Operations" and "Risk Factors" in the Company's Annual Report on Form 10-K for the year- ended December 31, 2007, and in other reports or documents the Company files with, or furnishes to, from time to time the SEC. This information should also be read in conjunction with the Company's Consolidated Financial Statements and the Notes thereto contained in the Company's Annual Report on Form 10-K for the year-ended December 31, 2007, and in other reports or documents the Company files with, or furnishes to, from time to time the SEC. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Communications, Marketing & Investor Relations, +1-201-557-6954, , or Kara Fitzsimmons, Director, Media Relations, +1-201-356-1523, , or Ludwig Marek, Vice President, Marketing Communications - Institutional Group, +1-201-356-1506, , all of Knight Capital Group, Inc. Web site: http://www.knight.com/

Copyright

Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Nightstar Therapeutics Plc ADS.
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Nightstar Therapeutics Plc ADS.